The Maintenance Effect of Enstilar Foam in Combination With Otezla
Phase 4
- Conditions
- Psoriasis
- Interventions
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2020-10-09
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 30
- Registration Number
- NCT04555707
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
A Pilot Study on the Use of Seysara for Rosacea
Phase 4
Completed
- Conditions
- Acne Rosacea
- Interventions
- Dietary Supplement: Centrum Adult Multivitamin
- First Posted Date
- 2020-09-18
- Last Posted Date
- 2021-01-07
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 100
- Registration Number
- NCT04555525
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients
- First Posted Date
- 2019-02-21
- Last Posted Date
- 2020-08-26
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 20
- Registration Number
- NCT03848871
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
The Use of Oracea and Epiduo Forte in Severe Acne Patients
Phase 4
Completed
- Conditions
- Acne
- Interventions
- Drug: Adapalene/Benzoyl Peroxide Gel 0.3-2.5%
- First Posted Date
- 2018-03-07
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 22
- Registration Number
- NCT03457636
- Locations
- 🇺🇸
Skin Sciences, PLLC, Louisville, Kentucky, United States
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color
Phase 4
Completed
- Conditions
- Acne VulgarisPost Inflammatory Hyperpigmentation
- Interventions
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 21
- Registration Number
- NCT03402893
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
- First Posted Date
- 2016-12-22
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 20
- Registration Number
- NCT03000309
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris
- First Posted Date
- 2016-10-25
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 20
- Registration Number
- NCT02944461
- Locations
- 🇺🇸
Dermatology and Laser Surgery, Sacramento, California, United States
🇺🇸James Q. DelRosso DO, LLC, Las Vegas, Nevada, United States
🇺🇸DermResearch, PLLC, Louisville, Kentucky, United States
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
- First Posted Date
- 2014-05-28
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 22
- Registration Number
- NCT02147691
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel
- First Posted Date
- 2013-06-25
- Last Posted Date
- 2015-02-27
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 32
- Registration Number
- NCT01885910
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
Safety and Efficacy Study of Altabax Ointment in the Treatment of Secondarily Infected Atopic Dermatitis
Phase 4
Completed
- Conditions
- Atopic DermatitisSecondary Infection
- First Posted Date
- 2010-02-09
- Last Posted Date
- 2016-09-22
- Lead Sponsor
- Derm Research, PLLC
- Target Recruit Count
- 29
- Registration Number
- NCT01064947
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
© Copyright 2025. All Rights Reserved by MedPath